drugset

drugset / Trial / NCT07096791

A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum Depression

NCT07096791 ↗

Phase 2 Not yet recruiting 72 enrolled Chengdu Kanghong Pharmaceutical Co., Ltd.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a study evaluating the efficacy, and safety of KH607 in 72 participants diagnosed with Postpartum Depressive Disorder.

Timeline

Start: 2025-07
Primary completion: 2027-01
Completion: 2027-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	KH607	Unknown	30 mg	Oral

Indications